2016
DOI: 10.1590/0100-3984.2014.0012
|View full text |Cite
|
Sign up to set email alerts
|

Solitary pulmonary nodule and 18F-FDG PET/CT. Part 1: epidemiology, morphological evaluation and cancer probability

Abstract: Solitary pulmonary nodule corresponds to a common radiographic finding, which is frequently detected incidentally. The investigation of this entity remains complex, since characteristics of benign and malignant processes overlap in the differential diagnosis. Currently, many strategies are available to evaluate solitary pulmonary nodules with the main objective of characterizing benign lesions as best as possible, while avoiding to expose patients to the risks inherent to invasive methods, besides correctly de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
22
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 31 publications
1
22
0
1
Order By: Relevance
“…CT often has led to a significant overlap between benign and malignant nodules resulting in useless invasive procedures, such as surgical biopsies (6). Integrated fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) has been widely investigated in SPNs management (7,8) and it is reported as an accurate noninvasive test (9). However, 18 F-FDG-PET/CT presents a significant discordance between sensitivity (Se) and specificity (Spe) due to the presence of different conditions causing false positive (FP) or false negative (FN) results (10).…”
Section: Original Articlementioning
confidence: 99%
“…CT often has led to a significant overlap between benign and malignant nodules resulting in useless invasive procedures, such as surgical biopsies (6). Integrated fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) has been widely investigated in SPNs management (7,8) and it is reported as an accurate noninvasive test (9). However, 18 F-FDG-PET/CT presents a significant discordance between sensitivity (Se) and specificity (Spe) due to the presence of different conditions causing false positive (FP) or false negative (FN) results (10).…”
Section: Original Articlementioning
confidence: 99%
“…To use 18 F-FDG-PET/CT as an auxiliary tool in clinical decision-making, one should be aware of its limitations in the context of SPN. Due to the limited spatial resolution of 18 F-FDG-PET/CT, its use is not recommended for SPNs smaller than 8 mm (1,6,25) . Although the vast majority of pulmonary neoplasms have high 18 F-FDG avidity, some tumors do not, including mucinous carcinomas (26) or pulmonary metastases, in which the primary tumor also has a low glycolytic activity (24) .…”
Section: D a Bmentioning
confidence: 99%
“…Cases with low probability of malignancy (< 5%) are usually managed by active surveillance, whereas those with high probability (> 65%) biopsy or surgery is indicated (1,5) . Cases with intermediate probability of malignancy are usually biopsied for diagnostic clarification (6) . However, biopsy is an invasive procedure that can lead to a significant number of false-negative results (7) .…”
Section: Introductionmentioning
confidence: 99%
“…An SPN which might represent the early stages of lung cancer is a well marginated rounded abnormality in the lung with a diameter less than 3 cm. Early detection of SPNs at an appropriate time contributes to the enhancement of the survival rate [2].…”
Section: Introductionmentioning
confidence: 99%